Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
These tips reinforce discipline, such as setting clear categories, automating transfers, and reviewing results monthly.
17,300 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A leading Bitcoin miner buys Cipher Mining's stake in three Texas sites, adding 4.4 EH/s and 120 MW to its fleet. The...
A major fund exit and shifting industry dynamics pushed acadia healthcare stock tanked into focus. This guide breaks ...
February brought a notable rotation in markets. Developed markets ex-US, gold, and REITs stood out as some of the top...
Investors chase the next big AI champion. This piece breaks down how a single AI stock could grow into a trillion-dol...
Versant Media Group launches a CNBC-based direct-to-consumer platform for retail investors, pairing journalism with A...
This week brought a sharp 19% drop in first majestic silver corporation shares. In this article, we break down the ma...
State Street’s 2026 ETF Outlook pushes a shift to multi-coin crypto ETFs, but a standout XRP ticker shows the sector ...
A hypothetical look at what could happen if a major AI tool faced a lawsuit over encouraging dangerous behavior. This...
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
Tesla's robotaxi venture is facing real-world hurdles in Texas. This article breaks down what those problems mean for...
Market pullbacks can be a doorway to solid, dependable gains. This guide reveals the best blue chip stocks to buy aft...